The contribution of various NOS gene products to HIV-1 coat protein (gp120)-mediated retinal ganglion cell injury

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 5, 1999, Pages 983-989

  Dreyer, Evan B ^a   Zurakowski, David ^b   Gorla, Madhu ^a   Vorwerk, Christian K ^a   Lipton, Stuart A ^c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; EXCITOTOXIN; FREE RADICAL; GENE PRODUCT; GLYCOPROTEIN GP 120; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; CYTOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA INJURY;

ANIMALS; CELL COUNT; CELL DEATH; ENZYME INHIBITORS; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV-1; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; RETINAL GANGLION CELLS;

EID: 0032994683     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Lipton SA, Gendelman HE. The dementia associated with the acquired immunodeficiency syndrome. N Engl J Med. 1995;332: 934-940.
2. Tenhula WN, Xu SZ, Madigan MC, Heller K, Freeman WR, Sadun AA. Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113: 14-20.
3. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in frontal cortex in AIDS brains. Acta Neuropathol (Berlin). 1990;80:90-92.
4. Everall IP, Luthbert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection Lancet 1991;337:1119-1121.
5. Wiley CA, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol. 1991;29:651-657.
6. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol. 1992;32:321-329.
7. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol. 1995;146:1121-1130.
8. Dickson DW. Apoptosis in the brain: physiology and pathology. Am J Pathol. 1995;146:1040-1044.
9. Adle-Biassette H, Levy Y, Colombel M, et al. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol. 1995;21: 218-227.
10. An SF, Gray F, Scaravilli F. Programmed cell death in brain of HIV-1 positive pre-AIDS patients (letter). Lancet. 1995;346:911-912.
11. An S, Gioimetto B, Scaravilli T, et al. Programmed cell death in brains of HIV-1 positive AIDS and pre-AIDS patients. Acta Neuropathol. 1996;91:169-173.
12. Gelbard HA, James H, Sharer L, et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol. 1995;21:208-217.
13. Lipton SA. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol. 1996;6:507-517.
14. Lipton SA. Neuropathogenesis of acquired immunodeficiency syndrome dementia. Curr Opin Neurol. 1997;10:247-253.
15. Masliah E, Heaton RK, Marcotte TD, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol. 1997;42:963-972.
16. Lipton SA. Neurobiology: HIV displays its coat of arms. Nature. 1994;367:113-114.
17. Deng H, Liu R, Ellmeier, W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661-666.
18. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 1996;85:1149-1158.
19. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996; 381:667-673.
20. Choe CM, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85:1135-1148.
21. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophagetropic HIV-1. Science. 1996;272:1955-1958.
22. Wu L, Gerard NP, Wyatt R, et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 1996;384:179-183.
23. Trkola A, Dragic T, Arthos J, et al. CD4-dependent antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 1996;384:184-187.
24. Brenneman DE, Westbrook GL, Fitzgerald SP, et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 1988;335:639-642.
25. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 1990;248:364-367.
26. Dreyer EB, Lipton SA. Toxic neuronal effects of the HIV coat protein gp120 may be mediated through macrophage arachidonic acid. Soc Neurosci Abstr. 1994;20:1049.
27. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natt Acad Sci USA. 1989;86:621-625.
28. Heyes MP, Brew BJ, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991;29:202-209.
29. Genis P, Jett M, Bernton EW, et al. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med. 1992;176:1703-1718.
30. Hayman M, Arbuthnott G, Harkiss G, et al. Neurotoxicity of peptide analogies of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience. 1993;53: 1-6.
31. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994;367:188-193.
32. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330: 613-622.
33. Gelbard HA, Nottet HSLM, Swindells S, et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol. 1994;68:4628-4635.
34. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J Exp Med. 1995;181:735-745.
35. Yen MW, Nottet HLM, Gendelman HE, Lipton SA. HIV-1 coat protein gp120 stimulates human macrophages to release L-cysteine, an NMDA agonist. Soc Neurosci Abstr. 1994;20:451.
36. Giulian D, Yu J, Li X, et al. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci. 1996;16:3139-3153.
37. i homeostasis and induce neurotoxicity in human embryonic neurons. Eur J Neurosci. 1995;7: 2285-2293.
38. Magnuson DS, Knudsen BE, Geiger JD, Brownstone RM, Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptor and causes neurotoxicity. Ann Neurol. 1995;37:373-380.
39. Wu P, Price P, Du B, Hatch WC, Terwilliger EF. Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. Neuroreport. 1996;7:1045-1049.
40. Lannuzel A, Barnier JV, Hery C, et al. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol. 1997;42:847-856.
41. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science. 1996;274: 602-605.
42. Lavi E, Strizki JM, Ulrich AM, et al. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol. 1997;151:1035-1042.
43. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 1991;7:111-118.
44. Müller WEG, Schröder HC, Ushijima H, Dapper J, Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol. 1992;226:209-214.
45. Lipton SA. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology. 1992;42:1403-1405.
46. Savio T, Levi G. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res. 1993;34:265-272.
47. Diop AG, Lesort M, Esclaire F, Sindou P, Couratier P, Hugon J. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci Lett. 1994;165:187-190.
48. Meucci O, Miller RJ. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-β1. J Neurosci. 1996;16:4080-4088.
49. Bagetta G, Corasaniti MT, Malorni W, et al. The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. Neuroreport. 1996;7:1722-1724.
50. Charriaut-Marlangue C, Aggoun-Zouaoui R A., Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci. 1996;19:109-114.
51. 2+ homeostasis and rescues cortical neurons from apoptotic death. J Neurosci Res. 1997; 49:600-607.
52. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA. 1991;88:6368-6371.
53. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883-1885.
54. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
55. Lo EH, Hara H, Rogowska J, et al. Temporal correlation mapping analysis of the hemodynamic penumhra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke. 1996; 27:1381-1385.
56. Hewett SJ, Csernansky CA, Choi DW. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron. 1994;13:487-494.
57. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci. 1997;17:9157-9164.
58. Vorwerk CK, Hyman BT, Miller JW, et al. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity. Invest Ophthalmol Vis Sci. 1997;38:2038-2044.
59. Djamgoz MBA, Aguilo R, Greenstreet EH, Reynolds R, Wilkin GP. Histochemistry of NADPH-diaphorase - a marker for neuronal nitric oxide synthase - in the carp retina. Neurochem Int. 1996;28: 283-291.
60. Lau KS, So KF, Tay D, Leung MC. NADPH-diaphorase neurons in the retina of the hamster. J Camp Neurol. 1994;350:550-558.
61. Liepe BA, Stone C, Koistinaho J, Copenhagen DR. Nitric oxide synthase in Müller cells and neurons of salamander and fish retina J Neurosci. 1994;14:7641-7654.
62. Osborne NN, Barnett NL, Herrera AJ. NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res. 1993;610:194-198.
63. Vaccaro TM, Cobcroft MD, Provis JM, Mitrofanis J. NADPH-diaphorase reactivity in adult and developing cat retinae. Cell Tissue Res. 1991;265:371-379.
64. Wässle H, Chun MH, Müller F. Amacrine cells in the ganglion cell layer in the cat retina. J Comp Neurol. 1987;265:391-408.
65. Yamamoto R, Bredt DS, Snyder SH, Stone RA. The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience. 1993;54:189-200.
66. Dawson VL, Dawson TM, Uhl GR, Snyder SH. Human immunodeficiency virus-1 coat protein neurotoxicity mediated by nitric oxide in priman cortical cultures. Proc Natl Acad Sci USA. 1993;90: 3256-3259.
67. Bagetta G, Corasaniti MT, Aloe L, et al. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc Natl Acad Sci USA. 1996;93:928-933.
68. Bagetta G, Corasaniti MT, Costa N, Berliocchi L, Finazzi-Agrò A, Nisticò G. The human immunodeficiency virus type I (HIV-1) glycoprotein gp120 reduces the expression of neuronal nitric oxide synthase in the hippocampus but not in the cerebral cortex and medial septal nucleus of rat. Neurosci Lett. 1997;224:75-78.
69. Dighiero P, Reux I, Hauw JJ, Fillet AM, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci Lett. 1994;166:31-34.
70. Mollace V, Colasanti M, Persichini T, Bagetta G, Lauro GM, Nisticò G. HIV gp120 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun. 1993;194:439-445.
71. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 1996;274:1917-1921.
72. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.
73. Lipton SA, Choi Y-B, Pan Z-H, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
74. Sautter J, Sabel BA. Recovery of brightness discrimination in adult rats despite progressive loss of retrogradely labelled retinal ganglion cells after controlled optic nerve crush. Eur J Neurosci. 1993;5:680-690.
75. Sterio D. The unbiased estimation of number and sizes of arbitrary particles using the disector method. J Microsc. 1984;134:127-136.
76. West M. New stereological methods for counting neurons. Neurobiol Aging. 1993;14:275-285.
77. Coggleshall R. A consideration of neural counting methods. Trends Neurosci. 1992;15:9-13.
78. Dräger UC, Olsen JF. Ganglion cell distribution in the retina of the mouse. Invest Ophthalmol Vis Sci. 1981;20:285-293.
79. Liu CJ, Chaturvedi N, Barnstable CJ, Dreyer EB. Retinal Thy-1 expression during development. Invest Ophthalmol Vis Sci. 1996; 37:1469-1472.
80. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52:591-611.
81. Zar JH. Biostatistical Analysis. Saddle River, NJ: Prentice Hall; 1996:212-217.
82. Toggas SM, Masliah E, Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res. 1996;706:303-307.
83. Dawson VL, Dawson TM, Hartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993;13:2651-2661.
84. Lipton SA. Treating AIDS dementia. Science, 1997;276:1629-1630.